100%
Skip to main content
Platform
GovTribe AI
AI-powered insights to accelerate your government contracting workflow.
MCP Server
Connect GovTribe to your AI tools.
Beacon
Find and connect with key government decision-makers.
Profiles
Federal Agencies
Federal Contract Vehicles
Federal Grant Programs
Major Defense Acquisition Programs
NAICS Categories
PSC Categories
States
Jurisdictions
NIGP Categories
UNSPSC Categories
Vendors
Enrichment By Clearbit
Reports
New Entrants
Funding Analysis
Vehicle Analysis
Groups
Capture
Pipelines
Pursuits
Alerts
Teaming
Data
Awards
Forecasts
Federal Opportunities
State & Local Opportunities
Files
Prime and Subcontractors
Activity
Search
Exports
Solutions
Use Case
Opportunity Identification
Capture Management
Competitive Intelligence
Teaming & Partner Identification
Proposal Management
Strategic Leadership
Go-to-Market Strategy
Industry
Federal Contractors
State & Local Contractors
Grant Seekers
Government Agencies
Research & Consulting
Pricing
More
About Us
Features
Get A Demo
Sign Up
Blog
User Guide
Data Model
GovTribe for Agents
Login
Contact sales
Try for free
Login
Contact sales
Try for free
All Federal Contract Awards
Purchase Order HHSN268201600279A
Award Date
9/13/16
Potential Completion Date
11/1/16
Potential Value
$38K
Overview
Contacts
Activity
1
Transactions
1
Subawards
Opportunity Stack
Similar Awards
Federal Agency
National Heart Lung and Blood Institute
Awardee
C S Bio Co TZAPMSMZ4MM6
Ultimate Awardee
Not listed
NAICS Category
325199 - All Other Basic Organic Chemical Manufacturing
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Description
CUSTOM EXENDIN-4 PEPTIDES
Posted 9/13/16
5
1
Name
Description
Solicitation Number
FederalAgency
Type
PostedDate
Custom Exendin-4 Peptide
Added: Aug 30, 2016 10:15 am INTRODUCTIONTHIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA) on behalf of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), intends to negotiate and award a Purchase Order without providing for full and open competition (Including brand-name) to C S Bio, 20 Kelly CT, Menlo Park, CA 94025 for custom made Exendin-4 Peptides.NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODEThe intended procurement is classified under NAICS code 325199, All other basic organic chemical manufacturing, with a Size Standard of 1,000 employees.REGULATORY AUTHORITYThe resultant contract will include all applicable provisions and clauses in effect tough the Federal Acquisition Circular (FAC) 05-89 effective 15 AUG 2016.This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition teshold ($150,000).STATUTORY AUTHORITY This acquisition is conducted under the authority of 41 U.S.C. 253(c) under provisions of the statutory authority of FAR Subpart FAR 6.302-1-Only one responsible source and no other supplies or services will satisfy agency requirements 41 U.S.C. 253(c)(1).DESCRIPTION OF REQUIREMENTBackground The National Institutes of Health (NIH) is the nation's leading medical research agency, and the primary Federal agency conducting and supporting medical discoveries that improve people's health and save lives. The mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to improve health by leading the development and accelerating the application of biomedical technologies. The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care. The Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at NIBIB does research to identify disease-specific biomarkers, to develop new molecular imaging probes, to apply newly developed probes in multimodality imaging, and to characterize novel imaging and therapeutic agents, both in vitro and in vivo. Using a multidisciplinary approach, LOMIN builds new systems for various biomedical applications ranging from the medical use of peptide-based diagnostic agents, to therapeutic agents, and even possible future applications of theranostics (diagnosis + therapy). The LOMIN is producing Evans blue dye conjugate from custom peptides for treatment of type-2 diabetes in db/db mice and cynomolgus monkeys. The NIBIB has a requirement for more custom made Exedin-4 peptides to continue the current research.Purpose and ObjectivesThe purpose of this contract is to procure custom made Exedin-4 peptides for use in the construction of chemical analogs for testing in biological systems for imaging and therapy applications. The objective of this protocol is to continue the current research involving the peptides and scale up the synthesis and test the compound in more mice and primates to obtain statistically significant results.Project DescriptionThe contractor shall provide the following product:1: Product name: C S BIO Exendin-4; Description: custom peptide; Quantity: 20 gramsDelivery:Overnight Shipping upon receipt of awardNational Institutes of Health, NIBIB10 Center Drive Building 10Bethesda, MD 20892CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATIONOnly one source is available; the determination by the Government to make a single-sole source is based upon the market research conducted as prescribed in FAR Part 10- specifically the results of the Sources Sought notice NHLBl-CSB-EB-2016-274-KEW posted 8/19/16 that C S BIO is the sole contractor capable of providing the required custom peptides, no other vendor provided a capability statement. C S Bio does not authorize 3rd party resellers to distribute the Exendin-4 Peptide, C S Bio is the sole source provider. The Peptides are unique because C S BIO customizes standard Exendin-4 Peptides by adding to the formula, the custom formula is proprietary to C S BIO. The LOMIN lab needs to continue using this formula to keep results consistent with prior year results. Use of a different formula will invalidate current research data and compromise the comparisons to prior year research.CLOSING STATEMENTThis synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov."A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.All responses must be received by 9/6/16 0900 EST and must reference number NHLBI-CSB-EB-2016-297-KEW. Responses may be submitted electronically to Kyle Wisor, Kyle.Wisor@nih.gov, or by U.S. mail to the National Heart, Lung, and Blood Institute, Office of Acquisitions, COAC Services Branch,6701 Rockledge Drive, Suite 6150B, Bethesda, MD 20892-7902, Attention: Kyle Wisor. Fax responses will not be accepted."All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."
NHLBI-CSB-EB-2016-297-KEW
Department of Health and Human Services National Institutes of Health
Award Notice 1/1
8/30/16, 10:15 AM
5
1
Mod #
Description
ReasonForModification
Federal Obligation
Date
Not listed
CUSTOM EXENDIN-4 PEPTIDES
Not listed
$37.5k
9/13/16